Form 4 for EW Edwards Lifesciences
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-17 · accession 0001225208-23-006019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-17 | EW | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | -8,496 | 19.2K | -31% | $0 | |
| I | 2023-05-17 | 2023-05-17 | EW | Ullem Scott B. | CFO, CVP | G - Gift | $0.00 | +8,496 | 266.3K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | G | D | 8,496 | $0.00 | 19,248 | D By Trust | — | — | |
| 2 | Common | Common Stock | 2023-05-17 | G | A | 8,496 | $0.00 | 266,318 | I | — | — |